India News | Maha Govt to Buy Anti-viral Drugs on Big Scale: Minister

Get latest articles and stories on India at LatestLY. Amid complaints of shortage of anti-viral drugs Remdesivir and Tocilizumab, Maharashtra minister Anil Deshmukh on Friday said the government will buy them "on a big scale" to ensure that they are available for the needy across the state "soon".

India (File Image)

Mumbai, Jul 10 (PTI) Amid complaints of shortage of anti-viral drugs Remdesivir and Tocilizumab, Maharashtra minister Anil Deshmukh on Friday said the government will buy them "on a big scale" to ensure that they are available for the needy across the state "soon".

He also said that the government will take strict action against black marketeers of the drugs, which are used in treating COVID-19 patients.

Also Read | Tamil Nadu Reports 3,680 New COVID-19 Cases, State Tally Reaches 1,30,261: Live News Breaking & Coronavirus Updates on July 10, 2020.

The Home Minister made the remarks following his meeting with Food and Drugs Administration Minister Rajendra Shingne here.

There is no vaccine availableto treat COVID-19 patients yet.

Also Read | Delhi: Junior Resident Doctor Allegedly Jumps From 10th Floor of AIIMS Hostel, Critical.

Speaking to reporters after the meeting, Deshmukh said that there has been a big demand for the drugs in Maharashtra as well as outside the state.

"The state government is going to buy remdesivir and tocilizumab on a big scale. The state government has started the process of purchasing the drugs to ensure it is available for the needy across the state. It will be available soon," Deshmukh said.

He said the police department and the Food and Drugs Administration department will take joint action in case there are instances of black marketing.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)

Share Now

Share Now